You just read:

Pfizer's Inflectra, Takeda's Entyvio, and Janssen's Simponi Projected to Gain Ground in the Increasingly Competitive Ulcerative Colitis Market

News provided by

Spherix Global Insights

Jul 07, 2017, 04:00 ET